Department of Anesthesiology
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is C  [Clear All Filters]
2008
Jia F, Yue M, Chandra D, Homanics GE, Goldstein PA, Harrison NL.  2008.  Isoflurane is a potent modulator of extrasynaptic GABA(A) receptors in the thalamus.. J Pharmacol Exp Ther. 324(3):1127-35.
Liantonio A, Picollo A, Carbonara G, Fracchiolla G, Tortorella P, Loiodice F, Laghezza A, Babini E, Zifarelli G, Pusch M et al..  2008.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.. Proc Natl Acad Sci U S A. 105(4):1369-73.
Liantonio A, Picollo A, Carbonara G, Fracchiolla G, Tortorella P, Loiodice F, Laghezza A, Babini E, Zifarelli G, Pusch M et al..  2008.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.. Proc Natl Acad Sci U S A. 105(4):1369-73.
Roepke TK, Kontogeorgis A, Ovanez C, Xu X, Young JB, Purtell K, Goldstein PA, Christini DJ, Peters NS, Akar FG et al..  2008.  Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f).. FASEB J. 22(10):3648-60.
Jia F, Yue M, Chandra D, Keramidas A, Goldstein PA, Homanics GE, Harrison NL.  2008.  Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus.. J Neurosci. 28(1):106-15.
2007
Lichtman AD, Carullo V, Minhaj M, Karkouti K.  2007.  Case 6--2007: massive intraoperative thrombosis and death after recombinant activated factor VII administration.. J Cardiothorac Vasc Anesth. 21(6):897-902.
Chambers TAnn, Bagai A, Ivascu N.  2007.  Current trends in coronary artery disease in women.. Curr Opin Anaesthesiol. 20(1):75-82.
Mani M, Lee SYoon, Lucast L, Cremona O, Di Paolo G, De Camilli P, Ryan TA.  2007.  The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals.. Neuron. 56(6):1004-18.
Charlson ME, Peterson JC, Krieger KH, Hartman GS, Hollenberg JP, Briggs WM, Segal AZ, Parikh M, Thomas SJ, Donahue RG et al..  2007.  Improvement of outcomes after coronary artery bypass II: a randomized trial comparing intraoperative high versus customized mean arterial pressure.. J Card Surg. 22(6):465-72.
Ouyang W, Jih T-Y, Zhang T-T, Correa AM, Hemmings HC.  2007.  Isoflurane inhibits NaChBac, a prokaryotic voltage-gated sodium channel.. J Pharmacol Exp Ther. 322(3):1076-83.
Picollo A, Liantonio A, Babini E, Camerino DConte, Pusch M.  2007.  Mechanism of interaction of niflumic acid with heterologously expressed kidney CLC-K chloride channels.. J Membr Biol. 216(2-3):73-82.
Liantonio A, Giannuzzi V, Picollo A, Babini E, Pusch M, D Camerino C.  2007.  Niflumic acid inhibits chloride conductance of rat skeletal muscle by directly inhibiting the CLC-1 channel and by increasing intracellular calcium.. Br J Pharmacol. 150(2):235-47.
Heerdt PM, Lane P, Pan BY, Schaefer U, Crabtree M, Hong R, Singer AAM, Levi R, Park BJ.  2007.  Nitrosative stress and myocardial sarcoplasmic endoreticular calcium adenosine triphosphatase subtype 2a activity after lung resection in swine.. Anesthesiology. 107(6):954-62.
Castillo MD, Heerdt PM.  2007.  Pulmonary resection in the elderly.. Curr Opin Anaesthesiol. 20(1):4-9.
Frederick RO, Bergeman L, Blommel PG, Bailey LJ, McCoy JG, Song J, Meske L, Bingman CA, Riters M, Dillon NA et al..  2007.  Small-scale, semi-automated purification of eukaryotic proteins for structure determination.. J Struct Funct Genomics. 8(4):153-66.
Chiu P-L, Pagel MD, Evans J, Chou H-T, Zeng X, Gipson B, Stahlberg H, Nimigean CM.  2007.  The structure of the prokaryotic cyclic nucleotide-modulated potassium channel MloK1 at 16 A resolution.. Structure. 15(9):1053-64.
Chiu P-L, Pagel MD, Evans J, Chou H-T, Zeng X, Gipson B, Stahlberg H, Nimigean CM.  2007.  The structure of the prokaryotic cyclic nucleotide-modulated potassium channel MloK1 at 16 A resolution.. Structure. 15(9):1053-64.
2006
Liantonio A, Picollo A, Babini E, Carbonara G, Fracchiolla G, Loiodice F, Tortorella V, Pusch M, Camerino DConte.  2006.  Activation and inhibition of kidney CLC-K chloride channels by fenamates.. Mol Pharmacol. 69(1):165-73.
Liantonio A, Picollo A, Babini E, Carbonara G, Fracchiolla G, Loiodice F, Tortorella V, Pusch M, Camerino DConte.  2006.  Activation and inhibition of kidney CLC-K chloride channels by fenamates.. Mol Pharmacol. 69(1):165-73.
Kjaer K, Comerford M, Kondilis L, DiMaria L, Abramovitz S, Kiselev M, Samuels J, Gadalla F, Leighton BL.  2006.  Oral sodium citrate increases nausea amongst elective Cesarean delivery patients.. Can J Anaesth. 53(8):776-80.
Kim Y-R, Paik H-J, Ober CK, Coates GW, Mark SS, Ryan TE, Batt CA.  2006.  Real-time analysis of enzymatic surface-initiated polymerization using surface plasmon resonance (SPR).. Macromol Biosci. 6(2):145-52.
Heerdt PM, Lane PB, Crabtree MJ, Park BJ.  2006.  Systemic oxidative stress associated with lung resection during single lung ventilation.. Eur J Cardiothorac Surg. 30(3):568-9;authorreply569-70.
Gill JM, Fleischut P, Haas S, Pellini B, Crawford A, Nash DB.  2006.  Use of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study.. Fam Med. 38(5):349-54.
2005
Samuels J, Ng Y-S, Coupillaud C, Paget D, Meffre E.  2005.  Impaired early B cell tolerance in patients with rheumatoid arthritis.. J Exp Med. 201(10):1659-67.
Cacheaux LP, Topf N, Tibbs GR, Schaefer UR, Levi R, Harrison NL, Abbott GW, Goldstein PA.  2005.  Impairment of hyperpolarization-activated, cyclic nucleotide-gated channel function by the intravenous general anesthetic propofol.. J Pharmacol Exp Ther. 315(2):517-25.